NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-1.08 Cr | ₹-1.08 Cr | ₹-1.08 Cr | ₹-1.08 Cr | ₹-1.30 Cr |
What is the latest Cash Flow from Financing Activities ratio of NGL FINECHEM ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-1.08 Cr |
Mar2023 | ₹-1.08 Cr |
Mar2022 | ₹-1.08 Cr |
Mar2021 | ₹-1.08 Cr |
Mar2020 | ₹-1.30 Cr |
How is Cash Flow from Financing Activities of NGL FINECHEM Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-1.08 Cr | Negative | |
Mar2023 | ₹-1.08 Cr | Negative | |
Mar2022 | ₹-1.08 Cr | Negative | |
Mar2021 | ₹-1.08 Cr | Negative | |
Mar2020 | ₹-1.30 Cr | - |
Compare Cash Flow from Financing Activities of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹737.8 Cr | 15.5% | 8.8% | -51.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,584.0 Cr | 0.5% | 0.6% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹182,147.0 Cr | 3.7% | 5.1% | 49.1% | Stock Analytics | |
CIPLA | ₹120,941.0 Cr | -1% | 1.7% | 2.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,325.0 Cr | 3.8% | 6.8% | 22.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,138.0 Cr | -3.7% | 1.9% | -0.3% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 15.5% |
8.8% |
-51.1% |
SENSEX | 0.8% |
2.5% |
5.3% |
You may also like the below Video Courses